IMRIS receives FDA clearance for next generation VISIUS Surgical Theatre

IMRIS Inc. has announced U.S. Food and Drug Administration clearance of the newest generation VISIUS Surgical Theatre that integrates Siemens’ latest high-field MR scanners.

The new core imaging technology, based on Siemens Aera 1.5T(tesla) and Skyra 3.0T technology, helps IMRIS deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition and improved ease-of-use and workflow during neurosurgical procedures using intraoperative MRI (iMRI).

The addition of these MR systems expands the industry-leading 1.5T and 3.0T MRI choices hospitals have when considering the unique, ceiling-mounted IMRIS solution for intraoperative imaging which brings the MRI to the patient during the procedure.

The first installation of this new generation VISIUS Surgical Theatre will be a four-room hybrid operating room suite at Dartmouth-Hitchcock Medical Center in Lebanon, N.H.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X